Gillian Turner

818 total citations · 1 hit paper
13 papers, 531 citations indexed

About

Gillian Turner is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Gillian Turner has authored 13 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Genetics, 6 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Gillian Turner's work include Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (3 papers). Gillian Turner is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Lymphoma Diagnosis and Treatment (5 papers) and Viral-associated cancers and disorders (3 papers). Gillian Turner collaborates with scholars based in United Kingdom, Australia and Germany. Gillian Turner's co-authors include David Westerman, Christiane Pott, Andrew W. Roberts, Martin Dreyling, Kate Burbury, Mark A. Dawson, Rodney J. Hicks, John F. Seymour, Sarah‐Jane Dawson and Juliana Di Iulio and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Gillian Turner

12 papers receiving 521 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

2018 274 citations Constantine S. Tam, Mary Ann Anderson et al. New England Journal of Medicine profile →

Peers

Gillian Turner

GENET

PFM

ONCOL

HEMAT

MB

M. S. De Propris Italy

M. Lenoci Italy

Denise White United Kingdom

Ka Lung Wu Belgium

JR Downing United States

Bertrand Montpellier France

Yoshitomo Maesako Japan

Ángel Ramírez Páyer Spain

Stefan Norin Sweden

Swapna Thota United States

M. S. De Propris Italy

Gillian Turner

156 ×0.5

GENET

132 ×0.5

PFM

130 ×0.6

ONCOL

194 ×1.1

HEMAT

92 ×0.9

MB

Citations per year, relative to Gillian Turner Gillian Turner (= 1×) peers M. S. De Propris

Countries citing papers authored by Gillian Turner

Since Specialization

Citations

This map shows the geographic impact of Gillian Turner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gillian Turner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gillian Turner more than expected).

Fields of papers citing papers by Gillian Turner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gillian Turner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gillian Turner. The network helps show where Gillian Turner may publish in the future.

Co-authorship network of co-authors of Gillian Turner

This figure shows the co-authorship network connecting the top 25 collaborators of Gillian Turner. A scholar is included among the top collaborators of Gillian Turner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gillian Turner. Gillian Turner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Davis, Joanne E., Sasanka M. Handunnetti, Gillian Turner, et al.. (2019). Long Term Responses to Venetoclax and Ibrutinib in Mantle Cell Lymphoma Are Associated with Immunological Recovery and Prognostic Changes in Inflammatory Biomarkers. Blood. 134(Supplement_1). 2791–2791.

2.

Tam, Constantine S., Mary Ann Anderson, Christiane Pott, et al.. (2018). Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma. New England Journal of Medicine. 378(13). 1211–1223. 274 indexed citations breakdown →

3.

Tam, Constantine S., Andrew W. Roberts, Mary Ann Anderson, et al.. (2017). Combination ibrutinib (Ibr) and venetoclax (Ven) for the treatment of mantle cell lymphoma (MCL): Primary endpoint assessment of the phase 2 AIM study.. Journal of Clinical Oncology. 35(15_suppl). 7520–7520. 6 indexed citations

4.

Turner, Gillian, et al.. (2015). Resolution of Roth spots in chronic myeloid leukaemia after treatment with imatinib. British Journal of Haematology. 170(6). 744–744. 1 indexed citations

5.

Bowles, Kristian M., Gillian Turner, & J. Z. Wimperis. (2004). Resolution of chronic severe refractory thrombocytopenia after treatment of hypothyroidism. Journal of Clinical Pathology. 57(9). 995–996. 14 indexed citations

6.

Saltman, David L., Stephen P. Hunger, & Gillian Turner. (2003). Molecular Analysis of Chromosome Aberrations in Hematological Malignancies: Southern Hybridization. Humana Press eBooks. 29. 437–448. 1 indexed citations

7.

Jackson, Graham, P R Taylor, Graeme Smith, et al.. (2001). A multicentre, open, non‐comparative phase II study of a combination of fludarabine phosphate, cytarabine and granulocyte colony‐stimulating factor in relapsed and refractory acute myeloid leukaemia and de novo refractory anaemia with excess of blasts in transformation. British Journal of Haematology. 112(1). 127–137. 99 indexed citations

8.

Rowe, David W., et al.. (1996). A case of mature B‐cell ALL with coexistence of t(1;19) and t(14;18) and expression of the E2A/PBX1 fusion gene. British Journal of Haematology. 94(1). 133–135. 9 indexed citations

9.

Turner, Gillian, Fiona M. Ross, & A S Krajewski. (1995). Detection of t(14;18) in British follicular lymphoma using cytogenetics, Southern blotting and the polymerase chain reaction. British Journal of Haematology. 89(1). 223–225. 25 indexed citations

10.

Maung, Z. T., et al.. (1994). Transfusion‐associated graft‐versus‐host disease in fludarabine‐treated B‐chronic lymphocytic leukaemia. British Journal of Haematology. 88(3). 649–652. 40 indexed citations

11.

Turner, Gillian & M M Reid. (1993). What is marrow fibrosis after treatment of neuroblastoma?. Journal of Clinical Pathology. 46(1). 61–63. 4 indexed citations

12.

Saltman, David L., et al.. (1990). Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; Evidence of leukemic origin by immunoglobulin gene rearrangement. Leukemia Research. 14(4). 381–387. 41 indexed citations

13.

Saltman, David L., et al.. (1989). Telomeric associations in a lymphoblastoid cell line from a patient with B-cell follicular lymphoma. Cytogenetic and Genome Research. 50(4). 230–233. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact